-
1
-
-
0028843552
-
Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
-
Non-small Cell Lung Cancer Collaborative Group
-
Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311 (1995) 899-909
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
-
2
-
-
0028154069
-
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients
-
Le Chevalier T., Brisgand D., Douillard J.Y., Pujol J.L., Alberola V., Monnier A., et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 12 (1994) 360-367
-
(1994)
J Clin Oncol
, vol.12
, pp. 360-367
-
-
Le Chevalier, T.1
Brisgand, D.2
Douillard, J.Y.3
Pujol, J.L.4
Alberola, V.5
Monnier, A.6
-
3
-
-
0033950286
-
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial
-
Bonomi P., Kim K., Fairclough D., Cella D., Kugler J., Rowinsky E., et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol 18 (2000) 623-631
-
(2000)
J Clin Oncol
, vol.18
, pp. 623-631
-
-
Bonomi, P.1
Kim, K.2
Fairclough, D.3
Cella, D.4
Kugler, J.5
Rowinsky, E.6
-
4
-
-
0029098178
-
Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response and survival analysis
-
Langer C.J., Leighton J.C., Comis R.L., O'Dwyer P.J., McAleer C.A., Bonjo C.A., et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response and survival analysis. J Clin Oncol 13 (1995) 1860-1870
-
(1995)
J Clin Oncol
, vol.13
, pp. 1860-1870
-
-
Langer, C.J.1
Leighton, J.C.2
Comis, R.L.3
O'Dwyer, P.J.4
McAleer, C.A.5
Bonjo, C.A.6
-
5
-
-
0042413836
-
Randomized, multinational phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer
-
The TAX 326 Study Group
-
Fossella F., Pereira J.R., von Pawel J., Pluzanska A., Gorbounova V., Kaukel E., et al., The TAX 326 Study Group. Randomized, multinational phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer. J Clin Oncol 21 (2003) 3016-3024
-
(2003)
J Clin Oncol
, vol.21
, pp. 3016-3024
-
-
Fossella, F.1
Pereira, J.R.2
von Pawel, J.3
Pluzanska, A.4
Gorbounova, V.5
Kaukel, E.6
-
6
-
-
0032701095
-
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian lung cancer project
-
Crino L., Scagliotti G.V., Ricci S., De Marinis F., Rinaldi M., Gridelli C., et al. Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian lung cancer project. J Clin Oncol 17 (1999) 3522-3530
-
(1999)
J Clin Oncol
, vol.17
, pp. 3522-3530
-
-
Crino, L.1
Scagliotti, G.V.2
Ricci, S.3
De Marinis, F.4
Rinaldi, M.5
Gridelli, C.6
-
7
-
-
0041912766
-
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group
-
Gridelli C., Gallo C., Shepherd F.A., Illiano A., Piantedosi F., Robbiati S.F., et al. Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 21 (2003) 3025-3034
-
(2003)
J Clin Oncol
, vol.21
, pp. 3025-3034
-
-
Gridelli, C.1
Gallo, C.2
Shepherd, F.A.3
Illiano, A.4
Piantedosi, F.5
Robbiati, S.F.6
-
8
-
-
0028033227
-
Single-agent activity of weekly gemcitabine in advanced non-small cell lung cancer: a phase II study
-
Anderson H., Lund B., Bach F., Thatcher N., Walling J., and Hansen H.H. Single-agent activity of weekly gemcitabine in advanced non-small cell lung cancer: a phase II study. J Clin Oncol 12 (1994) 1821-1826
-
(1994)
J Clin Oncol
, vol.12
, pp. 1821-1826
-
-
Anderson, H.1
Lund, B.2
Bach, F.3
Thatcher, N.4
Walling, J.5
Hansen, H.H.6
-
9
-
-
0027412646
-
Phase II study of taxol in patients with untreated advanced non-small cell lung cancer
-
Murphy W.K., Fossela F.V., Winn R.J., Shin D.M., Hynes H.E., Gross H.M., et al. Phase II study of taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 85 (1993) 384-388
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 384-388
-
-
Murphy, W.K.1
Fossela, F.V.2
Winn, R.J.3
Shin, D.M.4
Hynes, H.E.5
Gross, H.M.6
-
10
-
-
0041464768
-
The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer
-
Le Chevalier T. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer. Semin Oncol 4 Suppl 10 (2003) 37-44
-
(2003)
Semin Oncol
, vol.4
, Issue.SUPPL. 10
, pp. 37-44
-
-
Le Chevalier, T.1
-
11
-
-
0027999966
-
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion
-
Eisenhauer E.A., ten Bokkel Huinink W.W., Swenerton K.D., Gianni L., Myles J., van der Burg M.E., et al. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol 12 (1994) 2654-2666
-
(1994)
J Clin Oncol
, vol.12
, pp. 2654-2666
-
-
Eisenhauer, E.A.1
ten Bokkel Huinink, W.W.2
Swenerton, K.D.3
Gianni, L.4
Myles, J.5
van der Burg, M.E.6
-
12
-
-
0035670904
-
A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer
-
Fidias P., Supko J.G., Martins R., Boral A., Carey R., Grossbard M., et al. A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer. Clin Cancer Res 7 (2001) 3942-3949
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3942-3949
-
-
Fidias, P.1
Supko, J.G.2
Martins, R.3
Boral, A.4
Carey, R.5
Grossbard, M.6
-
13
-
-
0034069620
-
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
-
Shepherd F.A., Dancey J., Ramlau R., Mattson K., Gralla R., O'Rourke M., et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 18 (2000) 2095-2103
-
(2000)
J Clin Oncol
, vol.18
, pp. 2095-2103
-
-
Shepherd, F.A.1
Dancey, J.2
Ramlau, R.3
Mattson, K.4
Gralla, R.5
O'Rourke, M.6
-
17
-
-
31444448873
-
Optimizing first-line treatment options for patients with advanced NSCLC
-
Wakelee H., and Belani C.P. Optimizing first-line treatment options for patients with advanced NSCLC. Oncologist 10 Suppl 3 (2005) 1-10
-
(2005)
Oncologist
, vol.10
, Issue.SUPPL. 3
, pp. 1-10
-
-
Wakelee, H.1
Belani, C.P.2
-
18
-
-
1342268525
-
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003
-
Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker Jr. S., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22 (2004) 330-353
-
(2004)
J Clin Oncol
, vol.22
, pp. 330-353
-
-
Pfister, D.G.1
Johnson, D.H.2
Azzoli, C.G.3
Sause, W.4
Smith, T.J.5
Baker Jr., S.6
-
19
-
-
23744437871
-
Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase III trials
-
Barlesi F., and Pujol J.L. Combination of chemotherapy without platinum compounds in the treatment of advanced non-small cell lung cancer: a systematic review of phase III trials. Lung Cancer 49 (2005) 289-298
-
(2005)
Lung Cancer
, vol.49
, pp. 289-298
-
-
Barlesi, F.1
Pujol, J.L.2
-
20
-
-
33144474858
-
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? a meta-analysis of phase III randomized trials
-
Pujol J.L., Barlesi F., and Daures J.P. Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? a meta-analysis of phase III randomized trials. Lung Cancer 51 (2006) 335-345
-
(2006)
Lung Cancer
, vol.51
, pp. 335-345
-
-
Pujol, J.L.1
Barlesi, F.2
Daures, J.P.3
-
21
-
-
33750368586
-
A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients
-
De Pas T., Putzu C., Curigliano G., Noberasco C., Sabrina B., Catania C., et al. A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients. Lung Cancer 54 (2006) 359-364
-
(2006)
Lung Cancer
, vol.54
, pp. 359-364
-
-
De Pas, T.1
Putzu, C.2
Curigliano, G.3
Noberasco, C.4
Sabrina, B.5
Catania, C.6
-
22
-
-
0036729263
-
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial
-
Kosmidis P., Mylonakis N., Nicolaides C., Kalophonos C., Samantas E., Boukovinas J., et al. Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol 20 (2002) 3578-3585
-
(2002)
J Clin Oncol
, vol.20
, pp. 3578-3585
-
-
Kosmidis, P.1
Mylonakis, N.2
Nicolaides, C.3
Kalophonos, C.4
Samantas, E.5
Boukovinas, J.6
-
23
-
-
0346560025
-
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975
-
Smit E.F., van Meerbeeck J.P., Lianes P., Debruyne C., Legrand C., Schramel F., et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 21 (2003) 3909-3917
-
(2003)
J Clin Oncol
, vol.21
, pp. 3909-3917
-
-
Smit, E.F.1
van Meerbeeck, J.P.2
Lianes, P.3
Debruyne, C.4
Legrand, C.5
Schramel, F.6
-
24
-
-
0017705147
-
Tumor size, sensitivity to therapy, and design of treatment schedules
-
Norton L., and Simon R. Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep 61 (1977) 1307-1317
-
(1977)
Cancer Treat Rep
, vol.61
, pp. 1307-1317
-
-
Norton, L.1
Simon, R.2
-
25
-
-
0022504529
-
Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy
-
Day R.S. Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy. Cancer Res 46 (1986) 3876-3885
-
(1986)
Cancer Res
, vol.46
, pp. 3876-3885
-
-
Day, R.S.1
-
26
-
-
0034095853
-
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens
-
The TAX 320 Non-Small Cell Lung Cancer Study Group
-
Fossella F.V., DeVore R., Kerr R.N., Crawford J., Natale R.R., Dunphy F., et al., The TAX 320 Non-Small Cell Lung Cancer Study Group. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. J Clin Oncol 18 12 (2000) 2354-2362
-
(2000)
J Clin Oncol
, vol.18
, Issue.12
, pp. 2354-2362
-
-
Fossella, F.V.1
DeVore, R.2
Kerr, R.N.3
Crawford, J.4
Natale, R.R.5
Dunphy, F.6
-
27
-
-
0000619302
-
Sequential chemotherapy: rationale and clinical trial design in advanced non-small-cell carcinoma
-
Edelman M.J., and Gandara D.R. Sequential chemotherapy: rationale and clinical trial design in advanced non-small-cell carcinoma. Clin Lung Cancer 1 (1999) 122-127
-
(1999)
Clin Lung Cancer
, vol.1
, pp. 122-127
-
-
Edelman, M.J.1
Gandara, D.R.2
-
28
-
-
0035144916
-
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine
-
De Pas T., de Braud F., Mandala M., Curigliano G., Catania C., Ferretti G., et al. Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine. Lung Cancer 31 2-3 (2001) 267-270
-
(2001)
Lung Cancer
, vol.31
, Issue.2-3
, pp. 267-270
-
-
De Pas, T.1
de Braud, F.2
Mandala, M.3
Curigliano, G.4
Catania, C.5
Ferretti, G.6
-
29
-
-
33744794305
-
Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study
-
Lung Cancer Committee of the Hellenic Oncology Research Group
-
Makrantonakis P., Ziotopoulos P., Agelidou A., Polyzos A., Ziras A., Chandrinos V., et al., Lung Cancer Committee of the Hellenic Oncology Research Group. Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study. Lung Cancer 53 1 (2006) 85-90
-
(2006)
Lung Cancer
, vol.53
, Issue.1
, pp. 85-90
-
-
Makrantonakis, P.1
Ziotopoulos, P.2
Agelidou, A.3
Polyzos, A.4
Ziras, A.5
Chandrinos, V.6
-
30
-
-
0035195450
-
Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer A multicenter phase II study
-
Agelaki S., Bania H., Kouroussis C., Blazoyiannakis G., Souglakos J., Tsiafaki X., et al. Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer A multicenter phase II study. Lung Cancer 34 Suppl 4 (2001) S77-S80
-
(2001)
Lung Cancer
, vol.34
, Issue.SUPPL. 4
-
-
Agelaki, S.1
Bania, H.2
Kouroussis, C.3
Blazoyiannakis, G.4
Souglakos, J.5
Tsiafaki, X.6
-
31
-
-
27544503230
-
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
-
Thatcher N., Chang A., Parikh P., Rodrigues Pereira J., Ciuleanu T., von Pawel J., et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 366 9496 (2005) 1527-1537
-
(2005)
Lancet
, vol.366
, Issue.9496
, pp. 1527-1537
-
-
Thatcher, N.1
Chang, A.2
Parikh, P.3
Rodrigues Pereira, J.4
Ciuleanu, T.5
von Pawel, J.6
-
32
-
-
34248385777
-
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study
-
Chang A., Parikh P., Thongprasert S., Tan E.H., Perng R.P., Ganzon D., et al. Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study. J Thorac Oncol 1 (2006) 847-855
-
(2006)
J Thorac Oncol
, vol.1
, pp. 847-855
-
-
Chang, A.1
Parikh, P.2
Thongprasert, S.3
Tan, E.H.4
Perng, R.P.5
Ganzon, D.6
|